drugset / Trial / NCT02312232
Pharmacokinetic Study in Healthy Males
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the pharmacokinetics of levodopa, carbidopa, 3-OMD and ODM-104 after repeated doses of 3 levodopa formulations given in combination with carbidopa and ODM-104.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 12.5 mg | — |
| Subject | Carbidopa | Unknown | 25 mg | — |
| Subject | Levodopa | Small molecule | 50 mg | — |
| Subject | Levodopa | Small molecule | 100 mg | — |
| Subject | ODM-104 | Unknown | 100 mg | — |